CCL2 and neoplasm: For example, in murine breast cancer, a rebound effect has been noted after the withdrawal of anti-CCL2 treatment, which has been associated with increased mobilization and infiltration of bone-marrow monocytes in the tumor and consequent acceleration of lung metastasis [78].